Analysts predict that Alcentra Capital Corp (NASDAQ:ABDC) will report earnings of $0.27 per share for the current quarter, according to Zacks. Four analysts have made estimates for Alcentra Capital’s earnings. Alcentra Capital reported earnings per share of $0.45 in the same quarter last year, which would suggest a negative year over year growth rate of 40%. The company is scheduled to issue its next earnings report on Thursday, March 15th.
According to Zacks, analysts expect that Alcentra Capital will report full year earnings of $1.30 per share for the current year. For the next fiscal year, analysts expect that the business will report earnings of $1.05 per share. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow Alcentra Capital.
ABDC has been the topic of several analyst reports. ValuEngine cut Alcentra Capital from a “strong-buy” rating to a “buy” rating in a report on Friday, February 2nd. Raymond James Financial upgraded Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. Finally, UBS Group upgraded Alcentra Capital from an “underperform” rating to a “market perform” rating in a report on Thursday, January 11th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Alcentra Capital currently has a consensus rating of “Hold” and an average target price of $12.83.
Shares of Alcentra Capital (NASDAQ:ABDC) traded up $0.06 during mid-day trading on Wednesday, reaching $7.76. The company had a trading volume of 14,243 shares, compared to its average volume of 69,286. Alcentra Capital has a 1-year low of $7.00 and a 1-year high of $14.73. The company has a market capitalization of $109.69, a PE ratio of 16.17 and a beta of 0.55.
Alcentra Capital declared that its board has initiated a share repurchase program on Thursday, November 16th that allows the company to buyback $2.50 million in outstanding shares. This buyback authorization allows the asset manager to repurchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.